SCHEMBL30320779

SCHEMBL30320779

COC(=O)Nc1ccc(C(C)=O)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DEGS1 O15121 3/20 0.47
HCAR3 P49019 6/20 0.46
PTK2 Q05397 1/20 0.45
NNMT P40261 1/20 0.45
RAB9A P51151 3/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
TP53 P04637 2/20 0.42
TSHR P16473 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10033268 0.86 HCAR3 (0.64) HCAR3
SCHEMBL31727242 0.84 GRIN2B (0.48) DEGS1HCAR3PTK2NNMTRAB9A
SCHEMBL28658285 0.84 GRIN2B (0.48) DEGS1HCAR3PTK2NNMTRAB9A
SCHEMBL7093993 0.84 PTK2 (0.62) HCAR3PTK2NNMTRAB9AMAPT
SCHEMBL8590143 0.82 HCAR3 (0.53) DEGS1HCAR3PTK2NNMTRAB9A
SCHEMBL25702957 0.81 GSK3B (0.46) DEGS1HCAR3NNMT
SCHEMBL30320778 0.81 GSK3B (0.46) DEGS1HCAR3NNMT
SCHEMBL17577318 0.79 DEGS1 (0.60) DEGS1RAB9AMAPT
SCHEMBL2056409 0.79 RAB9A (0.70) RAB9AMAPTSMN1; SMN2TP53NFKB1
SCHEMBL7095081 0.78 GCK (0.52) DEGS1HCAR3RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183233-A1 Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors JANSSEN PHARMACEUTICA NV (BE) 2023-06-15 US disclosed
US-20230097157-A1 Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors JANSSEN PHARMACEUTICA NV (BE) 2023-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230097157-A1 Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors KLKB1, F2, SERPINC1 DEGS1 3066/4885HCAR3 2022/4885PTK2 832/4885
US-20230183233-A1 Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors KLKB1, F2, SERPINC1 DEGS1 3066/4885HCAR3 2022/4885PTK2 832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.